T36.7X2 Poisoning by antifungal antibiotics, systemically used, intentional self-harm

Name of the Condition

• Poisoning by antifungal antibiotics, systemically used, intentional self-harm

Summary

This condition involves intentional self-harm resulting from poisoning by systemically administered antifungal antibiotics. It includes cases where exposure to these agents is deliberate and leads to harmful effects. Documentation should specify the antifungal agent, the intentional nature of the exposure, and encounter details to ensure accurate coding.

Causes

Intentional self-harm may result from deliberate overdose or misuse of systemically used antifungal antibiotics. Adverse effects can stem from allergic reactions, drug interactions, or idiosyncratic responses. Underdosing may occur due to dosing errors, non-adherence, or inadequate prescription, leading to subtherapeutic levels.

Risk Factors

• Prior history of antifungal allergies or sensitivities.
• Polypharmacy increasing interaction risks.
• Renal or hepatic impairment affecting drug metabolism.
• Pediatric or geriatric populations with altered pharmacokinetics.
• Inadequate patient education on medication use.

Symptoms

• Gastrointestinal: Nausea, vomiting, diarrhea, abdominal pain.
• Allergic: Rash, urticaria, anaphylaxis.
• Systemic: Fever, hypotension, organ dysfunction (e.g., nephrotoxicity).
• Neurological: Dizziness, confusion, or seizures in severe cases.

Diagnosis

Diagnosis involves clinical assessment of symptoms, patient history, and laboratory tests to confirm exposure to antifungal antibiotics. Toxicology screening may be used to identify the specific agent. Documentation should clarify the intent of exposure and any contributing factors.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying cause. This may include decontamination, supportive care, and specific antidotes if available. Psychological evaluation and intervention are critical for intentional self-harm cases.

Prognosis and Follow-Up

Prognosis depends on the severity of exposure, timely intervention, and underlying health status. Follow-up care includes monitoring for delayed effects, addressing mental health needs, and ensuring adherence to prescribed therapies.

Complications

Complications may include organ damage (e.g., renal or hepatic failure), allergic reactions, or long-term psychological effects. Severe cases can lead to life-threatening conditions requiring intensive care.

Lifestyle & Prevention

Prevention involves proper medication storage, patient education on safe use, and addressing mental health concerns. Reducing access to potentially harmful substances and promoting adherence to prescribed regimens can mitigate risks.

When to Seek Professional Help

Seek immediate medical attention if symptoms of poisoning occur, especially after intentional exposure. Early intervention improves outcomes and reduces complications.

Tips for Medical Coders

Document the antifungal agent, intent of exposure (intentional self-harm), and encounter details. Ensure specificity in clinical notes to support accurate coding. Verify documentation aligns with the ICD-10-CM guidelines for intentional self-harm poisonings.